S.Amdt. 878

SA 878. Ms. SNOWE (for herself, Mr. Blumenthal, Mr. Schumer, Mr.
Grassley, Mr. Casey, Ms. Klobuchar, Ms. Collins, Mr. Coons, Mr. Kirk,
Mr. Wyden, Mr. Lautenberg, Mr. Brown, of Ohio, Mr. Sessions, and Mrs.
Feinstein) submitted an amendment intended to be proposed to amendment
SA 738 proposed by Mr. Inouye to the bill H.R. 2112, making
appropriations for Agriculture, Rural Development, Food and Drug
Administration, and Related Agencies programs for the fiscal year
ending September 30, 2012, and for other purposes; which was ordered to
lie on the table; as follows:

On page 153, after line 24, add the following:

SEC. 218. REPORT ON COMBATING SYNTHETIC DRUGS.

(a) In General.--Using amounts made available under this
Act, and not later than 90 days after the date of enactment
of this Act, the Director of the Office of National Drug
Control Policy, in coordination with the Attorney General,
shall submit to the Committee on the Judiciary of the Senate
and the Committee on the Judiciary of the House of
Representatives a report detailing the strategy of the
Federal Government for partnering with local law enforcement
agencies to target the spread of synthetic drugs, including
methylenedioxypyrovalerone and mephedrone.
(b) Contents.--The report submitted under subsection (a)
shall include the strategy of the Federal Government for--
(1) conducting public awareness campaigns and partnering
with local law enforcement officials, hospitals, and schools
to educate parents and young people about the dangers of
abusing synthetic drugs;

[[Page S6783]]

(2) addressing the rampant abuse and ease of access of
synthetic drugs in rural communities, where such problems can
multiply quickly while attention is placed on larger
population centers;
(3) using the High Intensity Drug Trafficking Areas program
to provide additional assistance to law enforcement agencies
operating in areas experiencing high levels of synthetic drug
trafficking;
(4) improving coordination with U.S. Customs and Border
Protection to seize shipments of synthetic drugs;
(5) developing and distributing test kits so that local law
enforcement agencies can better identify dangerous
individuals under the influence of synthetic drugs in the
field; and
(6) using the authority under section 203 of the Controlled
Substances Act (21 U.S.C. 813), to pursue law enforcement
actions against the distribution of synthetic drugs.
______